Syntermed Launches NeuroQ(TM) 3.5 - Nuclear Medicine Diagnostic Program at Alzheimer's Association 2010 International Conference

Published: Jul 12, 2010

ATLANTA--(BUSINESS WIRE)--At the Alzheimer’s Association 2010 International Conference (ICAD) July 10-14 in Honolulu, HI, Syntermed, Inc. launched NeuroQ™ version 3.5, a nuclear medicine quantitative software platform for analysis and image display of brain FDG-PET scans. NeuroQ can increase physician accuracy in diagnosing and differentiating the many types of dementia, compared to visual interpretation alone of FDG-PET. The update adds ten new features that improve performance, processing, speed, and quality control and is compatible with Syntermed Live™ for secure remote access to images and data.

Back to news